Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research Grade Dacetuzumab | Login | Research Grade Dacetuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Teneliximab | Login | Research Grade Teneliximab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Ravagalimab | Login | Research Grade Ravagalimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Bivatuzumab | Login | Research Grade Bivatuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Apamistamab | Login | Research Grade Apamistamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Urabrelimab | Login | Research Grade Urabrelimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Vatelizumab | Login | Research Grade Vatelizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Etrolizumab | Login | Research Grade Etrolizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Abrilumab | Login | Research Grade Abrilumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Volociximab | Login | Research Grade Volociximab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Abituzumab | Login | Research Grade Abituzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Etaracizumab | Login | Research Grade Etaracizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Intetumumab | Login | Research Grade Intetumumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Gatralimab | Login | Research Grade Gatralimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Bersanlimab | Login | Research Grade Bersanlimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Enlimomab | Login | Research Grade Enlimomab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Lorvotuzumab | Login | Research Grade Lorvotuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Besilesomab | Login | Research Grade Besilesomab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Tinurilimab | Login | Research Grade Tinurilimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Lemalesomab | Login | Research Grade Lemalesomab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Sulesomab | Login | Research Grade Sulesomab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Labetuzumab | Login | Research Grade Labetuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Cergutuzumab | Login | Research Grade Cergutuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Cibisatamab | Login | Research Grade Cibisatamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Altumomab | Login | Research Grade Altumomab | ||||||||||||||||
|
||||||||||||||||||


